Additionally, CD36 levels decrease initially at 3 h post-glucose in OLETF, ARB and MINUS, increasing further only in ARB at 6 h post-glucose, when elevated glucose levels have cleared circulation, suggesting that hepatic CD36 may not be stimulated by hyperglycemia during MetS. Here, CD36 is linked to metabolic syndrome.